Facilitation of apoptosis by cyclosporins A and H, but not FK506 in mouse bronchial eosinophils

European Journal of Pharmacology

Volumn 337, Issue 2-3, 1997, Pages 283-289

  Kitagaki, Kunihiko ^a   Nagai, Hiroichi ^b   Hayashi, Shigehiro ^a   Totsuka, Tetsuya ^a  

^a Sandoz Tsukuba Research Institute   (Japan)

^b GIFU PHARMACEUTICAL UNIVERSITY   (Japan)

Author keywords

Apoptosis; Cyclosporin A; Cyclosporin H; Eosinophil; FK506

Indexed keywords

CYCLOPHILIN; CYCLOSPORIN A; CYCLOSPORIN H; INTERLEUKIN 5; TACROLIMUS;

ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; ASTHMA; BINDING AFFINITY; CONTROLLED STUDY; EOSINOPHIL; ETIOLOGY; FACILITATION; LUNG LAVAGE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; APOPTOSIS; BRONCHI; BRONCHOALVEOLAR LAVAGE FLUID; CELLS, CULTURED; CYCLOSPORINE; EOSINOPHILS; GRANULOCYTE MACROPHAGE COLONY-STIMULATING FACTORS, RECOMBINANT; IMMUNOSUPPRESSIVE AGENTS; INTERLEUKIN-5; MALE; MICE; MICE, INBRED BALB C; PEPTIDYLPROLYL ISOMERASE; RECOMBINANT PROTEINS; TACROLIMUS;

EID: 0030664792     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(97)01278-8     Document Type: Article

References (35)

1. Alam R., Forsythe P., Stafford S., Fukuda Y. Transforming growth factor β abrogates the effects of hematopoietins on eosinophils and induces their apoptosis. J. Exp. Med. 179:1994;1041-1045.
2. Alexander A.G., Barnes N.C., Kay A.B. Trial of cyclosporin in corticosteroid-dependent chronic severe asthma. Lancet. 339:1992;324-328.
3. Carson D.A., Ribeiro J.M. Apoptosis and disease. Lancet. 341:1993;1251-1254.
4. Clutterbuck E.K., Hirst E.M.A., Sanderson C.J. Human interleukin-5 (IL-5) regulates the production of eosinophils in human bone marrow cultures: comparison and interaction with IL-1, IL-3, IL-6 and GM-CSF. Blood. 73:1989;1504-1512.
5. Dhein J., Walczak H., Bäumler C., Debatin K.-M., Krammer P.H. Autocrine T-cell suicide by APO-1/(Fas/CD95). Nature London. 373:1995;438-441.
6. Elwood W., Lotvall J.O., Barnes P.J., Chung K.F. Effect of dexamethasone and cyclosporin A on allergen-induced airway hyperresponsiveness and inflammatory cell responses in sensitized Brown-Norway rats. Am. Rev. Respir. Dis. 145:1992;1289-1294.
7. Flanagan W.M., Corthesy B., Bram R.J., Crabtree G.R. Nuclear association of a T-cell transcription factor blocked by FK-506 and cyclosporin A. Nature. 352:1991;803-807.
8. Fruman D.A., Burakoff S.J., Bierer B.E. Immunophilins in protein folding and immunosuppression. FASEB J. 8:1994;391-400.
9. Gottschalk A.R., Boise L.H., Thompson C.B., Quintans J. Identification of immunosuppressant-induced apoptosis in a murine B-cell line and its prevention by bcl-x but not bcl-2. Proc. Natl. Acad. Sci. USA. 91:1994;7350-7354.
10. Handschumacher R.C., Harding M.W., Rice J., Drugge R.J., Speicher D.W. Cyclophilin: A specific cytosolic binding protein for cyclosporin A. Science. 226:1984;544-547.
11. Hebestreit H., Yousefi S., Balatti I., Weber M., Crameri R., Simon D., Hartung K., Schapowal A., Blaser K., Simon H.-U. Expression and function of the Fas receptor on human blood and tissue eosinophils. Eur. J. Immunol. 26:1996;1775-1780.
12. Her E., Frazer J., Austen K.F., Owen W.F. Eosinophil hematopoietins antagonize the programmed cell death of eosinophils: Cytokine and glucocorticoid effects on eosinophils maintained by endothelial cell-conditioned medium. J. Clin. Invest. 88:1991;1982-1987.
13. Kitagaki K., Niwa S., Hoshiko K., Nagai H., Hayashi S., Totsuka T. Augmentation of apoptosis in bronchial exuded rat eosinophils by cyclosporin A. Biochem. Biophys. Res. Commun. 222:1996;71-77.
14. Kumar, A., Busse, W.W., 1995. Airway inflammation in asthma. Sci. Am. Sci. Med. Mar./Apr., 38-47.
15. Nicoletti I., Migliorati G., Pagaliacci M.C., Grignani F., Riccardi C. A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry. J. Immunol. Methods. 139:1991;271-279.
16. Norris A.A., Jackson D.M., Eady R.P. Protective effects of cyclophosphamide, cyclosporin A and FK506 against antigen-induced lung eosinophilia in guinea-pigs. Clin. Exp. Immunol. 89:1992;347-350.
17. Nunes I., Shapiro R.L., Rifkin D.B. Characterization of latent TGF-β activation by murine peritoneal macrophages. J. Immunol. 155:1995;1450-1459.
18. Ohnishi T., Kita H., Weiler D., Sur S., Sedgwick J.B., Calhoun W.J., Busse W.W., Abram J.S., Gleich G.J. IL-5 is the predominant eosinophil-active cytokine in antigen-induced pulmonary late-phase reaction. Am. Rev. Respir. Dis. 147:1993;901-907.
19. Peters D.H., Fitton A., Plosker G.L., Faulds D. Tacrolimus: A review of its pharmacology and therapeutic potential in hepatic and renal transplantation. Drugs. 46:1993;746-794.
20. Prashar Y., Khanna A., Sehaipal P., Sharma V.K., Suthanthiran M. Stimulation of transforming growth factor-β1 transcription by cyclosporine. FEBS Lett. 358:1995;109-112.
21. Shi Y.F., Sahai B.M., Green D.R. Cyclosporin A inhibits activation-induced cell death in T-cell hybridomas and thymocytes. Nature. 339:1989;625-626.
22. Sigal N.H., Dumont F., Durette P., Siekierka J.J., Peterson L., Rich D.H., Dunlap B.E., Staruch M.J., Melino M.R., Koprak S.L., Williams D., Witzel B., Pisano J. Is cyclophilin involved in the immunosuppressive and nephrotoxic mechanism of action of cyclosporin A? J. Exp. Med. 173:1991;619-628.
23. Simon H.-U., Blaser K. Inhibition of programmed eosinophil death: A key pathogenic event for eosinophilia. Immunol. Today. 16:1995;53-55.
24. Stern M., Meagher L., Savill J., Haslett C. Apoptosis in human eosinophils: Programmed cell death in the eosinophil leads to phagocytosis by macrophages and is modulated by IL-5. J. Immunol. 148:1992;3543-3549.
25. Tsuyuki S., Bertrand C., Erard F., Trifilieff A., Tsuyuki J., Wesp M., Anderson G.P., Coyle A.J. Activation of the Fas receptor on lung eosinophils leads to apoptosis and the resolution of eosinophilic inflammation of the airways. J. Clin. Invest. 96:1995;2924-2931.
26. Von Wartburg A., Traber R. Chemistry of the natural cyclosporin metabolites. Prog. Allergy. 38:1986;28-45.
27. Walker C., Virchow J.C., Bruijnzeel P.L.B., Blaser K. T-cell subsets and their soluble products regulate eosinophilia in allergic and non-allergic asthma. J. Immunol. 146:1991;1829-1835.
28. Wallen N., Kita H., Weiler D., Gleich G.J. Glucocorticoids inhibit cytokine-mediated eosinophil survival. J. Immunol. 147:1991;3490-3495.
29. Wenzel-Seifert K., Seifert R. Cyclosporin H is a potent and selective formyl peptide receptor antagonist: Comparison with N-t-butoxycarbonyl-L-phenylalanyl-L-leucyl-L-phenylalanyl-L-leucyl-L- phenylalanine and cyclosporins A, B, C, D and E. J. Immunol. 150:1993;4591-4599.
30. Wicker L.S., Boltz R.C. Jr., Matt V., Nichols E.A., Peterson L.B., Sigal N.H. Suppression of B-cell activation by cyclosporin A, FK506 and rapamycin. Eur. J. Immunol. 20:1990;2277-2283.
31. Woolley K.L., Gibson P.G., Carty K., Wilson A.J., Woolley M.J. Eosinophil apoptosis and the resolution of airway inflammation in asthma. Am. J. Resp. Crit. Care Med. 154:1996;237-243.
32. Yamaguchi S., Nagai H., Tanaka H., Tsujimoto M., Tsuruoka N. Time course study for antigen-induced airway hyperreactivity and the effect of soluble IL-5 receptor. Life Sci. 54:1994;471-475.
33. Yamaguchi Y., Suda T., Suda J., Eguchi M., Miura Y., Harada N., Tominaga A., Takatsu K. Purified interleukin-5 supports the terminal differentiation and proliferation of murine eosinophilic precursors. J. Exp. Med. 167:1988;43-56.
34. Yamaguchi Y., Suda T., Ohta S., Tominaga K., Miura Y., Kasahara T. Analysis of the survival of mature human eosinophils: Interleukin-5 prevents apoptosis in mature human eosinophils. Blood. 78:1991;2542-2547.
35. Yousefi S., Hoessli D.C., Blaser K., Mills G.B., Simon H.-U. Requirement of Lyn and Syk tyrosine kinases for the prevention of apoptosis by cytokines in human eosinophils. J. Exp. Med. 183:1996;1407-1414.